Corrigendum to "Deciphering the cis-regulatory elements of co-expressed genes in PCOS by in silico analysis" [Gene 408 (2008) 72-84] (DOI:10.1016/j.gene.2007.10.026);Deciphering the cis-regulatory elements of co-expressed genes in PCOS by in silico analysis

Gene

Volumn 408, Issue 1-2, 2008, Pages 72-84

  Sarkar, Chiradeep ^a   Maitra, Anurupa ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

Author keywords

cis elements; Microarray; Transcription factor; Transcription Factor Binding Sites

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CCAAT BINDING FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HELIX LOOP HELIX PROTEIN; PROTEIN C JUN; PROTEIN E47; PROTEIN STAF; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; DNA MICROARRAY; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; NUCLEOTIDE SEQUENCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; UNINDEXED SEQUENCE;

EID: 37549034291     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2008.11.002     Document Type: Erratum

References (108)

1. Amemiya-Kudo M., et al. Sterol regulatory element-binding proteins activate insulin gene promoter directly and indirectly through synergy with BETA2/E47. J. Biol. Chem. 280 (2005) 34577-34589
2. Apt D., Liu Y., and Bernard H.U. Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner. Nucleic Acids Res. 22 (1994) 3825-3833
3. Artlett C.M., Chen S.J., Varga J., and Jimenez S.A. Modulation of basal expression of the human α1(I) procollagen gene (COL1A1) by tandem NF-1/Sp1 promoter elements in normal human dermal fibroblasts. Matrix Biol. 17 (1998) 425-434
4. Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., and Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89 (2004) 2745-2749
5. Bucher P.J. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. Mol. Biol. 212 (1990) 563-578
6. Burkart A.D., Mukherjee A., and Mayo K.E. Mechanism of repression of the inhibin α-subunit gene by inducible 3′, 5′ -cyclic adenosine monophosphate early repressor. Mol. Endocrinol. 20 (2006) 584-597
7. Candeliere G.A., Jurutka P.W., Haussler M.R., and St-Arnaud R. A composite element binding the vitamin D receptor, retinoid X receptor alpha, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter. Mol. Cell. Biol. 16 (1996) 584-592
8. Camp T.A., Rahal J.O., Mayo, and K.E. Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizaing hormone receptor messenger RNAs in the rat ovary. Mol. Endocrinol. 5 (1991) 1405-1417
9. Cardinaux J.R., Chapel S., and Wahli W. Complex organization of CTF/NF-I, C/EBP, and HNF3 binding sites within the promoter of the liver-specific vitellogenin gene. J. Biol. Chem. 269 (1994) 32947-32956
10. Carlone D.L., and Richards J.S. Functional interactions, phosphorylation and levels of 3′,5′-cyclic adenosine monophosphate-regulatory element binding protein and steroidogenic factor-1 mediate hormone-regulated and constitutive expression of aromatase in gonadal cells. Mol. Endocrinol. 11 (1997) 292-304
11. Caudy M., Vaessin H., Brand M., Tuma R., Jan L.Y., and Jan Y.N. daughterless, a gene essential for both neurogenesis and sex determination in Drosophila, has sequence similarities to myc and the achaete-scute complex. Cell 55 (1988) 1061-1067
12. Chaudhry A.Z., Lyons G.E., and Gronostajski R.M. Expression patterns of the four nuclear factor I genes during mouse embryogenesis indicate a potential role in development. Dev. Dyn. 208 (1997) 313-325
13. Chodosh L., Baldwin A., Carthew R., and Sharp P. Human CCAAT-binding proteins have heterologous subunits. Cell 53 (1988) 11-24
14. Cooke D.W., and Lane M.D. The transcription factor nuclear factor I mediates repression of the GLUT4 promoter by insulin. J. Biol. Chem. 274 (1999) 12917-12924
15. Daneshmand S., Weitsman S.R., Navab A., Jakimiuk A.J., and Magoffin D.A. Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17α-hydroxylase/C(17-20) lyase promoters. Fertil. Steril. 77 (2002) 274-280
16. Darne C.H., et al. Ubiquitous transcription factors NF1 and Sp1 are involved in the androgen activation of the mouse vas deferens protein promoter. Mol. Cell. Endocrinol. 132 (1997) 13-23
17. Davis R.L., Cheng P.F., Lassar A.B., and Weintraub H. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 60 (1990) 733-746
18. Diao F.Y., et al. The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. J. Mol. Endocrinol. 33 (2004) 59-72
19. Dierich A., et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo. Targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13612-13617
20. Docherty H.M., Hay C.W., Ferguson L.A., Barrow J., Durward E., and Docherty K. Relative contribution of PDX-1, MafA and E47/β2 to the regulation of the human insulin promoter. Biochem. J. 389 Pt 3 (2005) 813-820
21. Dorn A., Bollekens J., Staub A., Benoist C., and Mathis D. A multiplicity of CCAAT box binding proteins. Cell 50 (1987) 863-872
22. Dunaif A., Wu X., Lee A., and Kandarakis E.D. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am. J. Physiol. Endocrinol. Metab. 281 (2001) 392-399
23. Ehrmann D.A., Barnes R.B., and Rosenfield R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr. Rev. 16 (1995) 322-353
24. El-Jack A.K., Hamm J.K., Pilch P.F., and Farmer S.R. Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARγ and C/EBPα. J. Biol. Chem. 274 (1999) 7946-7951
25. Escobar-Morreale H.F., Luque-Ramírez M., and San Millán J.L. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr. Rev. 26 (2005) 251-282
26. Foulkes N.S., and Sassone-Corsi P. Transcription factors coupled to the cAMP-signalling pathway. Biochim. Biophys. Acta 1288 (1996) 101-121
27. Gharani N., et al. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum. Mol. Genet. 6 (1997) 397-402
28. Gross D.N., Farmer S.R., and Pilch P.F. Glut4 storage vesicles without Glut4: transcriptional regulation of insulin-dependent vesicular traffic. Mol. Cell. Biol. 24 16 (2004) 7151-7162
29. Guo I.C., Huang C., Wang C.K.L., and Chung B. Activating protein-1 cooperates with steroidogenic factor-1 to regulate 3′, 5′ -cyclic adenosine 5′ -monophosphate-dependent human CYP11A1 transcription in vitro and in vivo. Endocrinology 148 (2007) 1804-1812
30. 12Ala polymorphism in the PPARγ gene. J. Clin. Endocrinol. Metab. 87 (2002) 772-775
31. Hay C.W., and Docherty K. Comparative analysis of insulin gene promoters: implications for diabetes research. Diabetes 55 (2006) 3201-3213
32. Hay C.W., Sinclair E.M., Bermano G., Durward E., Tadayyon M., and Docherty K. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site. J. Endocrinol. 186 (2005) 353-365
33. Hay C.W., Ferguson L.A., and Docherty K. ATF-2 stimulates the human insulin promoter through the conserved CRE2 sequence. Biochim. Biophys. Acta 1769 (2007) 79-91
34. Heckert L.L., Sawadogo M., Daggett M.A.F., and Chen J.K. The USF proteins regulate transcription of the follicle-stimulating hormone receptor but are insufficient for cell-specific expression. Mol. Endocrinol. 14 (2000) 1836-1848
35. Henthorn P., Kiledjian M., and Kadesch T. Two distinct transcription factors that bind the immunoglobulin enhancer pLE5/KE2 motif. Science 247 (1990) 467-470
36. Hoeffler J.P., Meyer T.E., Yun Y., Jameson J.L., and Habener J.F. Cyclic AMP-responsive DNA-binding protein: structure based on a cloned placental cDNA. Science 242 (1988) 1430-1433
37. Hu J.-S., Olson E.N., and Kingston R.E. HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol. Cell. Biol. 12 (1992) 1031-1042
38. Inagaki N., Maekawa T., Sudo T., Ishii S., Seino Y., and Imura H. c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1045-1049
39. Jansen E., et al. Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol. Endocrinol. 12 (2004) 3050-3063
40. Jaatinen T.A., Penttila T.L., Kaipia A., Ekfors T., Parvinen M., and Toppari J. Expression of inhibin alpha, beta A and beta B messenger ribonucleic acids in the normal human ovary and in polycystic ovarian syndrome. J. Endocrinol. 143 (1994) 127-137
41. Jones K.A., Kadonaga J.T., Rosenfeld P.J., Kelly T.J., and Tjian R. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48 (1987) 79-89
42. Kaestner K.H., Christy R.J., and Lane M.D. Mouse insulin-responsive glucose transporter gene: characterization of the gene and trans-activation by the CCAAT/enhancer binding protein. Proc. Natl. Acad. Sci. U. S. A. l87 (1990) 251-255
43. Kanei-Ishii C., and Ishii S. Dual enhancer activities of the cyclic-AMP responsive element with cell type and promoter specificity. Nucleic Acids Res. 17 (1989) 1521-1536
44. Kara C.J., Liou H.C., Ivashkiv L.B., and Glimcher L.H. A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. Mol. Cell. Biol. 10 4 (1990) 1347-1357
45. Kel A.E., Gossling E., Reuter I., Cheremushkin E., Kel-Margoulis O.V., and Wingender E. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 31 (2003) 3576-3579
46. Lambert-Messerlian G., et al. Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin hyperstimulation. Biol. Reprod. 57 (1997) 1211-1216
47. Lan H.-C., Li H.-J., Lin G., Lai P.-Y., and Chung B.-C. Cyclic AMP Stimulates SF-1-Dependent CYP11A1 Expression through Homeodomain-Interacting Protein Kinase 3-Mediated Jun N-Terminal Kinase and c-Jun Phosphorylation. Molecular and Cellular Biology 27 (2007) 2027-2036
48. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84 (1999) 165-169
49. Lindahl R., Xiao G.H., Falkner K.C., and Prough R.A. Negative regulation of rat hepatic aldehyde dehydrogenase 3 by glucocorticoids. Adv. Exp. Med. Biol. 463 (1999) 159-164
50. Lum L.S.Y., Sultzman L.A., Kaufman R.J., Linzer D.I.H., and Wu B.J. A cloned human CCAAT-Box-binding factor stimulates transcription from the human hsp7O promoter. Mol. Cell. Biol. (1990) 6709-6717
51. Lu G., Schlichter D., and Wicks W.D. Interaction of a nuclear factor 1-like protein with a cAMP response element-binding protein in rat liver. Int. J. Biochem. 24 3 (1992) 455-464
52. Lu M., Seufert J., and Habener J.F. Pancreatic β-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein β. J. Biol. Chem. 272 (1997) 28349-28359
53. Manna P.R., et al. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Mol. Endocrinol. 16 1 (2002) 184-199
54. Marszalek B., et al. Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5′-UTR in patients with polycystic ovarian syndrome. Gynecol. Endocrinol. 15 (2001) 123-128
55. Massari M.E., and Murre C. Helix-loop-helix proteins: regulators of transcription in eukaryotic organisms. Mol. Cell. Biol. 20 (2000) 429-440
56. Matsuda S., Maekawa T., and Ishiis S. Identification of the functional domains of the transcriptional regulator CRE-BP1. J. Biol. Chem. 266 (1991) 18188-18193
57. Mermod N., O'Neill E.A., Kelly T.J., and Tjian R. The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell 58 (1989) 741-753
58. Meunier H., Rivier C., Evans R.M., and Vale W. Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 247-251
59. Mirasierra M., and Vallejo M. The homeoprotein Alx3 expressed in pancreatic beta-cells regulates insulin gene transcription by interacting with the basic helix-loop-helix protein E47. Mol. Endocrinol. 20 11 (2006) 2876-2889
60. Molina C.A., Foulkes N.S., Lalli E., and Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 75 (1993) 875-886
61. Mukherjee A., Park-Sarge O.-K., and Mayo K.E. Gonadotropins induce rapid phosphorylation of the 3′,5′-cyclic adenosine monophosphate response element binding protein in ovarian granulosa cells. Endocrinology 137 (1996) 3234-3245
62. Mukherjee A., Urban J., Sassone-Corsi P., and Mayo K.E. Gonadotropins regulate inducible cyclic adenosine 3′, 5′ -monophosphate early repressor in the rat ovary: implications for inhibin αsubunit gene expression. Mol. Endocrinol. 12 (1998) 785-800
63. Mukhopadhyay S.S., Wyszomierski S.L., Gronostajski R.M., and Rosen J.M. Differential interactions of specific nuclear factor I isoforms with the glucocorticoid receptor and STAT5 in the cooperative regulation of WAP gene transcription. Mol. Cell. Biol. 21 (2001) 6859-6869
64. Murre C., McCaw P.S., and Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and Myc proteins. Cell 56 (1989) 777-783
65. Murre C., et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58 (1989) 537-544
66. Myslinski E., Krol A., and Carbon P. ZNF76 and ZNF143 are two human homologs of the transcriptional activator Staf. J. Biol. Chem. 273 (1998) 21998-22006
67. Myslinski E., Geard M.A., Krol A., and Carbon P. A genome scale location analysis of human Staf/ZNF143-binding sites suggests a widespread role for human Staf/ZNF143 in mammalian promoters. J. Biol. Chem. 281 (2006) 39953-39962
68. Nebl G., and Cato A.C. NFI/X proteins: a class of NFI family of transcription factors with positive and negative regulatory domains. Cell. Mol. Biol. Res. 41 (1995) 85-95
69. Nelson V.L., Legro R.S., Strauss III J.F., and McAllister J.M. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol. Endocrinol. 13 6 (1999) 946-957
70. Nelson V.L., et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 86 (2001) 5925-5933
71. Orio F., et al. Exon 6 and 2 peroxisome proliferator-activated receptor-γ polymorphisms in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88 (2003) 5887-5892
72. Park B.H., Qiang L., and Farmer S.R. Phosphorylation of C/EBPβ at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol. Cell. Biol. 24 19 (2004) 8671-8680
73. Pei L., Dodson R., Schoderbek W.E., Maurer R.A., and Mayo K.E. Regulation of the αinhibin gene by cyclic adenosine 3′,5′-monophosphate after transfection into rat granulosa cells. Mol. Endocrinol. 5 (1991) 521-534
74. Piontkewitz Y., Enerback S., and Hedin L. Expression and hormonal regulation of the CCAAT enhancer binding protein-α during differentiation of rat ovarian follicles. Endocrinology 133 (1993) 2327-2333
75. Piontkewitz Y., Enerback S., and Hedin L. Expression of CCAAT enhancer binding protein-α (C/EBPα) in the rat ovary: implications for follicular development and ovulation. Dev. Biol. 179 (1996) 288-296
76. Quinn P.G. Distinct activation domains within cAMP response element-binding protein (CREB) mediate basal and cAMP-stimulated transcription. J. Biol. Chem. 268 (1993) 16999-17009
77. Richards J.S. New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol. Endocrinol. 15 (2001) 209-218
78. Richards J.S., Russell D.L., Robker R.L., Dajee M., and Alliston T.N. Molecular mechanisms of ovulation and luteinization. Mol. Cell. Endocrinol. 145 (1998) 47-54
79. Roberts V.J., Barth S., El-Roeiy A., and Yen S.S.C. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 79 (1994) 1434-1439
80. Roder K., Wolf S.S., Beck K.F., Abou M.J., and Schweizer M. Cooperative binding of NF-Y and Sp1 at the DNase I-hypersensitive site, fatty acid synthase insulin-responsive element 1. J. Biol. Chem. 272 (1997) 21616-21624
81. Rupp R.A., Kruse U., Multhaup G., Gobel U., Beyreuther K., and Sippel A.E. Chicken NFI/TGGCA proteins are encoded by at least three independent genes: NFI-A, NFI-B and NFI-C with homologues in mammalian genomes. Nucleic Acids Res. 18 (1990) 2607-2616
82. San Millán J.L., Sancho J., Calvo R.M., and Escobar-Morreale H.F. Role of the pentanucleotide (tttta)(n) polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertil. Steril. 75 (2001) 797-802
83. Santoro C., Mermod N., Andrews P.C., and Tjian R. A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature 334 (1988) 218-224
84. Schaub M., Myslinski E., Schuster C., Krol A., and Carbon P. Staf, a promiscuous activator for enhanced transcription by RNA polymerases II and IIII. EMBO J. 16 (1997) 173-181
85. Schuster C., Myslinski E., Krol A., and Carbon P. Staf, a novel zinc finger protein that activates the RNA polymerase III promoter of the selenocysteine tRNA gene. EMBO J. 14 (1995) 3777-3787
86. Spitz F., Salminen M., Demignon J., Kahn A., Daegelen D., and Maire P. A combination of MEF3 and NFI proteins activates transcription in a subset of fast-twitch muscles. Mol. Cell. Biol. 17 (1997) 656-666
87. Stocco D.M., Wang X., Jo Y., and Manna P.R. Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. Mol. Endocrinol. 19 (2005) 2647-2659
88. Sun X.-H., and Baltimore D. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64 (1991) 459-470
89. Takayama K., Morohashi K., Honda S., Hara N., and Omura T. Contribution of Ad4BP, a steroidogenic cell-specific transcription factor, to regulation of the human CYP11A and bovine CYP11B genes through their distal promoters. J. Biochem. (Tokyo) 116 (1994) 193-203
90. Taylor A.E., et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 82 (1997) 2248-2256
91. Tsilchorozidou T., Overton C., and Conway G.S. The pathophysiology of polycystic ovary syndrome. Clin. Endocrinol. 60 (2004) 1-17
92. Urbanek M., et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8573-8578
93. Vadigepalli R., Chakravarthula P., Zak D.E., Schwaber J.S., and Goyne G.E. PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. OMICS 7 3 (2003) 235-252
94. Walker W.H., Girardet C., and Habener J.F. Alternative exon splicing controls a translational switch from activator to repressor isoforms of transcription factor CREB during spermatogenesis. J. Biol. Chem. 271 (1996) 20145-21050
95. Waterworth D.M., et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 349 (1997) 986-990
96. Welt C.K., Taylor A.E., Fox J., Messerlian G.M., Adams J.M., and Schneyer A.L. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J. Clin. Endocrinol. Metab. 90 (2005) 5582-5587
97. Wickenheisser J.K., Quinn P.G., Nelson V.L., Legro R.S., Strauss J.F., and McAllister J.M. Differential activity of the cytochrome P450 17α-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J. Clin. Endocrinol. Metab. 85 (2000) 2304-2311
98. Wickenheisser J.K., Nelson V.L., Quinn P.G., and McAllister J.M. Increased cytochrome P450 17α-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1. Mol. Endocrinol. 18 3 (2004) 588-605
99. Wingender E., Dietze P., Karas H., and Knuppel R. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res. 24 (1996) 238-241
100. Wood J.R., et al. The molecular phenotype of Polycystic Ovary Syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J. Biol. Chem. 278 (2003) 26380-26390
101. Yamada K., et al. Cloning and functional expression of an E box-binding protein from rat granulosa cells. Biol. Reprod. 64 (2001) 1315-1319
102. Yamamoto K.K., Gonzalez G.A., Menzel P., Rivier J., and Montminy M.R. Characterization of a bipartite activator domain in transcription factor CREB. Cell 60 (1990) 611-6170
103. Yang B.S., Gilbert J.D., and Freytag S.O. Overexpression of Myc suppresses CCAAT transcription factor/nuclear factor 1-dependent promoters in vivo. Mol. Cell. Biol. 13 (1993) 3093-3102
104. Zhang H., Ramanathan Y., Soteropoulus P., Recce M.L., and Tolias P.P. EZ-Retrieve: a web-server for batch retrieval of coordinate-specified human DNA sequences and underscoring putative transcription factor-binding sites. Nucleic Acids Res. 30 (2002) e121
105. Zhang J.-W., Klemm D.J., Vinson C., and Lane M.D. Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein βgene during adipogenesis. J. Biol. Chem. 279 (2004) 4471-4478
106. Zheng G., and Yang Y.C. ZNF76, a novel transcriptional repressor targeting TATA-binding protein, is modulated by sumoylation. J. Biol. Chem. 279 (2004) 42410-42421
107. Zheng J., Wu J., and Sun Z. An approach to identify over-represented cis-elements in related sequences. Nucleic Acids Res. 31 (2003) 1995-2005
108. Zuo Y., Qiang L., and Farmer S.R. Activation of CCAAT/enhancer-binding protein (C/EBP) βexpression by C/EBPγ during adipogenesis requires a peroxisome proliferator-activated receptor-γ-associated repression of HDAC1 at the C/ebpα gene promoter. J. Biol. Chem. 281 (2006) 7960-7967